Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8194090 | 1.00 | LMNA (0.62) | LMNAADK | |
| SCHEMBL7204800 | 0.89 | LMNA (0.61) | LMNAADK | |
| SCHEMBL8193258 | 0.89 | LMNA (0.61) | LMNAADK | |
| SCHEMBL3818523 | 0.89 | LMNA (0.80) | LMNAADK | |
| SCHEMBL9410640 | 0.88 | LMNA (0.79) | LMNAADK | |
| SCHEMBL285147 | 0.88 | LMNA (0.79) | LMNAADK | |
| SCHEMBL3819600 | 0.88 | LMNA (0.58) | LMNAADK | |
| SCHEMBL7205985 | 0.88 | LMNA (0.58) | LMNAADK | |
| SCHEMBL8196428 | 0.88 | LMNA (0.58) | LMNAADK | |
| SCHEMBL7204593 | 0.88 | LMNA (0.65) | LMNAADK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1060183-B1 | 5'-DEOXYCYTIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-04-23 | — | — | EP | claimed |
| EP-1060183-A1 | 5'-DEOXYCYTIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-12-20 | — | — | EP | claimed |
| WO-1999040099-A1 | 5'-DEOXYCYTIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-08-12 | — | — | WO | claimed |
| EP-1060183-B1 | 5'-DEOXYCYTIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-04-23 | — | — | EP | disclosed |
| EP-1060183-A1 | 5'-DEOXYCYTIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2000-12-20 | — | — | EP | disclosed |
| WO-1999040099-A1 | 5'-DEOXYCYTIDINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 1999-08-12 | — | — | WO | disclosed |